Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical Mistletoe Extract in Superficial Bladder Cancer
NCT02106572Phase 3Terminated
- Sponsor
- ABNOBA GmbH
- Start
- Apr 2015
- Primary completion
- Mar 2026
- Modality
- PE (Plant Extract)
- Countries
- 2
01
Overview
A Phase 3 trial of abnobaVISCUM Fraxini in bladder cancer, sponsored by ABNOBA GmbH. Started Apr 2015; status: terminated.
02
Drugs
abnobaVISCUM Fraxini
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT02106572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02106572.